We are live on
!
Find out more
AQR Capital Management Portfolio holdings
AUM
$218B
1-Year Est. Return
29.41%
This Fund
S&P 500
This Quarter
Est. Return
-12.77%
1 Year Est. Return
+29.41%
3 Year Est. Return
+92.15%
5 Year Est. Return
+116.61%
10 Year Est. Return
+435.72%
AUM
$44.2B
AUM Growth
-$8.44B
(-16%)
Cap. Flow
-$301M
Cap. Flow
% of AUM
-0.68%
Top 10 Holdings %
Top 10 Hldgs %
14.01%
Holding
2,360
New
150
Increased
1,005
Reduced
998
Closed
187
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$209M |
| 2 |
CVS Health
CVS
|
+$195M |
| 3 |
Tyson Foods
TSN
|
+$136M |
| 4 |
ExxonMobil
XOM
|
+$135M |
| 5 |
LyondellBasell Industries
LYB
|
+$130M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Thermo Fisher Scientific
TMO
|
+$239M |
| 2 |
Microsoft
MSFT
|
+$204M |
| 3 |
Johnson & Johnson
JNJ
|
+$157M |
| 4 |
Amazon
AMZN
|
+$144M |
| 5 |
Walmart Inc
WMT
|
+$137M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.23% |
| 2 | Healthcare | 16.49% |
| 3 | Financials | 11.74% |
| 4 | Industrials | 11.47% |
| 5 | Consumer Discretionary | 10.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CSGS
1201
DELISTED
CSG Systems International
CSGS
| $1.63M | ﹤0.01% |
27,320
+1,916
| +8% | +$116K |
|
1202
Old National Bancorp
ONB
$10.3B
| $1.62M | ﹤0.01% |
109,699
+40,538
| +59% | +$625K |
|
|
WCC
1203
WESCO International
WCC
$17.8B
| $1.62M | ﹤0.01% |
15,103
-1,056
| -7% | -$130K |
|
1204
First Hawaiian
FHB
$3.34B
| $1.62M | ﹤0.01% |
73,139
-21,644
| -23% | -$543K |
|
1205
KBR
KBR
$4.74B
| $1.61M | ﹤0.01% |
34,132
-3,098
| -8% | -$153K |
|
1206
SITE Centers
SITC
$155M
| $1.61M | ﹤0.01% |
152,895
+38,460
| +34% | +$454K |
|
1207
Telefônica Brasil
VIV
$18.6B
| $1.61M | ﹤0.01% |
177,231
-164,482
| -48% | -$1.69M |
|
1208
Tandem Diabetes Care
TNDM
$1.63B
| $1.6M | ﹤0.01% |
27,441
+4,171
| +18% | +$342K |
|
1209
DNOW Inc
DNOW
$3.01B
| $1.6M | ﹤0.01% |
163,870
-15,772
| -9% | -$168K |
|
1210
Teledyne Technologies
TDY
$31.6B
| $1.6M | ﹤0.01% |
4,346
+447
| +11% | +$186K |
|
1211
Beazer Homes USA
BZH
$874M
| $1.6M | ﹤0.01% |
132,659
+2,632
| +2% | +$38.5K |
|
1212
Itaú Unibanco
ITUB
$82.7B
| $1.6M | ﹤0.01% |
423,393
+13,560
| +3% | +$60.2K |
|
|
NXRT
1213
NexPoint Residential Trust
NXRT
$631M
| $1.6M | ﹤0.01% |
25,562
+5,348
| +26% | +$407K |
|
1214
UDR
UDR
$12B
| $1.59M | ﹤0.01% |
34,862
+9,215
| +36% | +$465K |
|
1215
AMC Global Media
AMCX
$486M
| $1.59M | ﹤0.01% |
54,569
+10,775
| +25% | +$380K |
|
1216
Skywest
SKYW
$4.19B
| $1.59M | ﹤0.01% |
74,735
+15,328
| +26% | +$403K |
|
1217
American Homes 4 Rent
AMH
$12.2B
| $1.58M | ﹤0.01% |
45,187
-67,013
| -60% | -$2.54M |
|
|
AAT
1218
American Assets Trust
AAT
$1.37B
| $1.58M | ﹤0.01% |
53,158
+14,367
| +37% | +$481K |
|
1219
Helmerich & Payne
HP
$4.25B
| $1.58M | ﹤0.01% |
36,652
+23,091
| +170% | +$1.07M |
|
1220
S&T Bancorp
STBA
$1.81B
| $1.57M | ﹤0.01% |
57,338
+12,252
| +27% | +$347K |
|
|
CVE.WS
1221
DELISTED
Cenovus Energy Inc Warrants
CVE.WS
| $1.57M | ﹤0.01% |
112,828
| – | – |
|
1222
Banco Bradesco
BBD
$35B
| $1.57M | ﹤0.01% |
480,760
-49,288
| -9% | -$189K |
|
|
PRA
1223
DELISTED
ProAssurance
PRA
| $1.56M | ﹤0.01% |
66,240
+23,178
| +54% | +$544K |
|
1224
Select Water Solutions
WTTR
$2.72B
| $1.56M | ﹤0.01% |
229,405
+185,494
| +422% | +$1.5M |
|
1225
NETSCOUT
NTCT
$2.81B
| $1.56M | ﹤0.01% |
46,269
-16,248
| -26% | -$545K |
|
Similar funds
VGA
AQR Capital Management's Q2 2022 Portfolio in Review
As of Q2 2022, AQR Capital Management held 2,360 positions worth $44.2B, down 16% from $52.7B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
AQR Capital Management's Q2 2022 filing shows 150 new, 1,005 increased, 998 reduced and 187 closed positions. Its largest new stake was Fluor: 339,891 shares worth $7.86M. The largest sale was Thermo Fisher Scientific, an estimated $239M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 23% a quarter earlier, followed by Healthcare and Financials.
- AQR Capital Management's largest Q2 2022 buy was Fluor: 339,891 shares worth $7.86M.
- AQR Capital Management added most to Gilead Sciences in Q2 2022, an estimated $209M increase.
- AQR Capital Management's biggest Q2 2022 reduction was Thermo Fisher Scientific, cutting an estimated $239M.
- AQR Capital Management fully exited Roku in Q2 2022, selling an estimated $32.5M.
- AQR Capital Management's ten largest holdings make up 14% of its $44.2B portfolio in Q2 2022.
- AQR Capital Management opened 150 new positions and closed 187 in Q2 2022.
- AQR Capital Management's portfolio value fell 16% quarter-over-quarter to $44.2B.
Based on AQR Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.